首页> 外文期刊>Journal of Clinical Immunology >Clinical and molecular characteristics of 35 Chinese children with Wiskott-Aldrich syndrome.
【24h】

Clinical and molecular characteristics of 35 Chinese children with Wiskott-Aldrich syndrome.

机译:35例中国儿童维斯科特-奥尔德里奇综合征的临床和分子特征。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Wiskott-Aldrich syndrome (WAS) is a rare primary immunodeficiency disease, with an incidence of 4/1,000,000 live male births. In China, an estimated number of 35 babies with WAS are born each year, but likely many remain undiagnosed. OBJECTIVES: The objectives of study were to review the clinical and molecular characteristics of a cohort of Chinese children with WAS and to describe the long-term outcome of those who underwent hematopoietic stem cell transplant (HSCT). MATERIALS AND METHOD: Records of 35 patients diagnosed with WAS during 1991-2008 were reviewed. Genetic diagnosis was established by direct gene sequencing. RESULTS: All patients had classical WAS phenotype. WASP mutations were identified in 33 patients from 29 families. Nine patients underwent HSCT at a mean age of 22.1 months (match-unrelated donor, n = 5; mismatched related donor, n = 2; matched-sibling donor, n = 2). Post-transplant immune hemolytic anemia and thrombocytopenia occurred in three patients with complete resolution. All patients survived without significant long-term complications and had full platelet, T and B lymphocyte recovery within 2 years post-transplant. CONCLUSION: In the past decade, there has been significant improvement in clinical and genetic diagnosis of WAS in Chinese. We demonstrated excellent long-term survival in patients who underwent HSCT. Early workup for transplant should be advocated for children with classical WAS before they suffer from major disease complications and morbidities.
机译:背景:维斯科特-奥尔德里奇综合症(WAS)是一种罕见的原发性免疫缺陷疾病,男性活产的发生率为4 / 1,000,000。在中国,估计每年有35名WAS婴儿出生,但仍有许多婴儿未被诊断。目的:本研究的目的是回顾一组中国WAS患儿的临床和分子特征,并描述接受造血干细胞移植(HSCT)的儿童的长期结局。材料与方法:回顾了1991-2008年间35例被诊断为WAS的患者的记录。通过直接基因测序来建立遗传诊断。结果:所有患者均具有经典的WAS表型。在来自29个家庭的33例患者中发现了WASP突变。九名患者接受HSCT的平均年龄为22.1个月(不匹配的供体,n = 5;不匹配的相关供体,n = 2;相匹配的同胞供体,n = 2)。完全治愈后,三名患者发生了移植后免疫性溶血性贫血和血小板减少症。所有患者均存活下来,没有明显的长期并发症,并且在移植后的2年内完全恢复了血小板,T和B淋巴细胞。结论:在过去的十年中,中国人WAS的临床和遗传诊断有了显着的进步。我们证明了接受HSCT的患者具有出色的长期存活率。对于患有经典WAS的儿童,应在其遭受重大疾病并发症和发病之前尽早进行移植检查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号